Astellas Pharma Inc.
ALPMF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $19,882 | $2,484,090 | $2,658,082 | $2,776,090 |
| - Cash | $1,940 | $215,399 | $188,372 | $179,865 |
| + Debt | $5,006 | $889,490 | $831,426 | $915,364 |
| Enterprise Value | $22,947 | $3,158,181 | $3,301,136 | $3,511,589 |
| Revenue | $3,544 | $505,794 | $459,294 | $517,408 |
| % Growth | -99.3% | 10.1% | -11.2% | – |
| Gross Profit | $2,610 | $410,965 | $382,436 | $418,885 |
| % Margin | 73.6% | 81.3% | 83.3% | 81% |
| EBITDA | $1,042 | $151,845 | $101,785 | $126,058 |
| % Margin | 29.4% | 30% | 22.2% | 24.4% |
| Net Income | $535 | $68,422 | $74,896 | -$97,660 |
| % Margin | 15.1% | 13.5% | 16.3% | -18.9% |
| EPS Diluted | 0.3 | 38.11 | 41.19 | -54.57 |
| % Growth | -99.2% | -7.5% | 175.5% | – |
| Operating Cash Flow | $1,551 | $54,837 | $101,075 | $16,026 |
| Capital Expenditures | -$91 | -$12,808 | -$9,699 | $2,294 |
| Free Cash Flow | $1,461 | $42,029 | $91,376 | $18,320 |